Stock listing
Cboe Canada:HELP Cybin, Inc. Stock
Home listing (Cboe Canada) of Cybin, Inc.
Follow Cybin, Inc. into a list and get an email when it puts out news.
Share price · Cboe Canada: HELP
$12.73 CAD +0.87 (+7.3%)
Close on Nov 6, 2026
- Day range
- $12.00 – $12.90 CADNov 6, 2026
- Volume
- 10,621 sharesNov 6, 2026
- Market cap
- —Left out: price × shares is far from the company's reported size
- 52-week range
- $5.30 – $20.88 CADLowest and highest trades, Nov 7, 2025 – Nov 6, 2026
- Traded on an average day
- $376,056 CADMedian day 19,178 shares · last 3 months, Aug 6, 2026 – Nov 6, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Cboe Canada:HELP · Home | $12.73 CAD | +0.87 (+7.3%) | 10,621 | $12.00 | $12.90 | $12.00 | $11.86 | Close on Nov 6, 2026 |
| NASDAQ:HELP | $8.96 USD | +0.57 (+6.8%) | 1,209,600 | $8.63 | $9.18 | $8.53 | $8.39 | Close on Nov 6, 2026 |
Daily closes
Last 3 months, Aug 6, 2026 – Nov 6, 2026 · Cboe Canada: HELP · CAD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $12.73 | +0.87 | +7.3% | $12.00 | $12.90 | $12.00 | 10,621 | |
| $11.86 | -0.30 | -2.5% | $12.39 | $12.39 | $11.60 | 8,958 | |
| $12.16 | -0.56 | -4.4% | $12.91 | $12.91 | $12.00 | 15,634 | |
| $12.72 | +0.37 | +3.0% | $12.51 | $13.25 | $12.51 | 11,296 | |
| $12.35 | -2.53 | -17.0% | $14.84 | $15.00 | $11.75 | 36,374 | |
| $14.88 | -0.19 | -1.3% | $14.65 | $15.30 | $14.60 | 10,932 | |
| $15.07 | -0.15 | -1.0% | $15.20 | $15.76 | $14.75 | 7,877 | |
| $15.22 | +0.38 | +2.6% | $14.90 | $15.31 | $14.65 | 4,125 | |
| $14.84 | +0.41 | +2.8% | $14.43 | $15.10 | $13.78 | 11,374 | |
| $14.43 | +0.11 | +0.8% | $13.95 | $15.25 | $13.95 | 7,721 | |
| $14.32 | -0.33 | -2.3% | $14.73 | $14.73 | $13.90 | 19,178 | |
| $14.65 | -0.40 | -2.7% | $14.70 | $15.82 | $14.47 | 17,518 | |
| $15.05 | -0.30 | -2.0% | $15.46 | $16.31 | $15.05 | 13,311 | |
| $15.35 | +0.34 | +2.3% | $15.10 | $16.30 | $15.10 | 11,508 | |
| $15.01 | +0.06 | +0.4% | $14.95 | $15.20 | $14.61 | 5,277 | |
| $14.95 | -0.80 | -5.1% | $15.85 | $15.85 | $14.80 | 12,716 | |
| $15.75 | +0.88 | +5.9% | $14.75 | $15.77 | $14.37 | 13,761 | |
| $14.87 | -0.20 | -1.3% | $15.00 | $15.00 | $14.55 | 13,540 | |
| $15.07 | -1.83 | -10.8% | $16.54 | $16.54 | $14.20 | 20,121 | |
| $16.90 | +1.61 | +10.5% | $15.62 | $17.17 | $14.90 | 9,673 | |
| $15.29 | +0.38 | +2.5% | $14.90 | $15.30 | $14.60 | 7,201 | |
| $14.91 | -0.39 | -2.5% | $15.34 | $15.34 | $14.90 | 11,865 | |
| $15.30 | -1.03 | -6.3% | $16.24 | $16.24 | $14.96 | 39,814 | |
| $16.33 | -0.28 | -1.7% | $16.50 | $16.68 | $16.04 | 25,488 | |
| $16.61 | -0.44 | -2.6% | $17.63 | $17.63 | $16.40 | 24,820 | |
| $17.05 | -0.55 | -3.1% | $17.55 | $17.70 | $16.50 | 22,443 | |
| $17.60 | -0.40 | -2.2% | $17.90 | $18.20 | $17.34 | 16,830 | |
| $18.00 | +0.05 | +0.3% | $17.95 | $18.36 | $17.65 | 9,920 | |
| $17.95 | +0.01 | +0.1% | $17.90 | $18.10 | $17.08 | 12,280 | |
| $17.94 | +0.06 | +0.3% | $17.90 | $18.15 | $17.79 | 9,565 | |
| $17.88 | -0.68 | -3.7% | $18.30 | $18.30 | $17.39 | 37,334 | |
| $18.56 | -0.80 | -4.1% | $19.60 | $19.60 | $18.10 | 41,402 | |
| $19.36 | +0.11 | +0.6% | $19.25 | $20.00 | $19.00 | 36,135 | |
| $19.25 | +1.70 | +9.7% | $17.80 | $19.68 | $17.55 | 49,908 | |
| $17.55 | -2.16 | -11.0% | $20.40 | $20.88 | $17.00 | 106,418 | |
| $19.71 | +0.79 | +4.2% | $19.71 | $19.71 | $19.71 | 1,000 | |
| $18.92 | +0.67 | +3.7% | $18.80 | $19.11 | $18.47 | 30,452 | |
| $18.25 | -0.75 | -3.9% | $19.17 | $19.17 | $18.12 | 11,519 | |
| $19.00 | +0.86 | +4.7% | $17.75 | $19.05 | $17.75 | 23,799 | |
| $18.14 | +0.31 | +1.7% | $18.39 | $18.71 | $17.60 | 21,709 | |
| $17.83 | -1.12 | -5.9% | $18.90 | $19.19 | $17.74 | 31,966 | |
| $18.95 | +1.81 | +10.6% | $17.14 | $19.17 | $16.90 | 24,442 | |
| $17.14 | +0.33 | +2.0% | $16.98 | $17.50 | $16.51 | 22,184 | |
| $16.81 | +0.49 | +3.0% | $16.65 | $16.90 | $15.90 | 11,840 | |
| $16.32 | -0.25 | -1.5% | $16.60 | $16.60 | $15.75 | 14,870 | |
| $16.57 | +0.39 | +2.4% | $16.30 | $16.66 | $15.85 | 14,306 | |
| $16.18 | -0.18 | -1.1% | $16.25 | $16.93 | $16.00 | 37,553 | |
| $16.36 | -0.64 | -3.8% | $17.10 | $17.10 | $15.60 | 29,208 | |
| $17.00 | -1.38 | -7.5% | $19.00 | $19.00 | $16.90 | 30,491 | |
| $18.38 | -0.65 | -3.4% | $19.16 | $19.16 | $18.20 | 25,018 | |
| $19.03 | -0.51 | -2.6% | $19.86 | $19.86 | $18.90 | 27,687 | |
| $19.54 | +1.46 | +8.1% | $18.35 | $19.80 | $18.23 | 53,315 | |
| $18.08 | +0.67 | +3.8% | $17.70 | $18.32 | $16.60 | 34,636 | |
| $17.41 | +0.31 | +1.8% | $17.30 | $17.75 | $17.25 | 13,155 | |
| $17.10 | +0.85 | +5.2% | $16.69 | $17.54 | $16.69 | 28,856 | |
| $16.25 | +0.10 | +0.6% | $16.50 | $16.53 | $16.10 | 11,097 | |
| $16.15 | +0.15 | +0.9% | $16.14 | $16.35 | $15.50 | 19,191 | |
| $16.00 | -0.61 | -3.7% | $16.79 | $16.79 | $15.90 | 21,584 | |
| $16.61 | +0.61 | +3.8% | $16.15 | $16.61 | $15.45 | 18,625 | |
| $16.00 | -0.055 | -0.3% | $16.30 | $16.60 | $15.85 | 19,212 | |
| $16.06 | +1.955 | +13.9% | $15.09 | $16.06 | $14.96 | 37,036 | |
| $14.10 | +0.15 | +1.1% | $14.29 | $14.43 | $13.90 | 10,421 | |
| $13.95 | -2.28 | -14.0% | $16.20 | $16.30 | $13.75 | 47,348 | |
| $16.23 | +0.83 | +5.4% | $15.40 | $16.23 | $15.40 | 32,507 | |
| $15.40 | +0.68 | +4.6% | $14.66 | $16.00 | $14.66 | 44,635 |
Splits
1 split · Cboe Canada: HELP · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-38 | Consolidation |
- Ticker
- Cboe Canada:HELP
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Cboe Canada
- Currency
- CAD
What changed lately
Latest news release · Nov 3, 2026
Helus Pharma to Participate in the Guggenheim Healthcare Innovation Conference
Latest earnings call · Nov 13, 2025
Cybin (Cboe Canada: HELP) Q2 2026 Earnings Call
Replay and transcript
Latest deck · August 2026
Investor Presentation (August 2026)
Investor deck · 45 slides
Calls
Replays
Cybin (Cboe Canada: HELP) Q2 2026 Earnings Call
Thu, Nov 13, 2025 · 8:00 AM ET
Watch TranscriptCybin (Cboe Canada: HELP) Q3 2022 Earnings Call
Thu, Feb 10, 2022 · 8:30 AM ET
Watch TranscriptCybin (Cboe Canada: HELP) Q2 2022 Earnings Call
Mon, Nov 15, 2021 · 4:30 PM ET
Watch Transcript
Latest news
Helus Pharma to Participate in the Guggenheim Healthcare Innovation Conference
Nov 3, 2026
Closed $12.72 (+3.0%) on Nov 3, 2026
Helus Pharma Announces Co-Founders' Transition from Executive Leadership as Company Advances Toward Next Stage of Development
Oct 27, 2026
Closed $14.84 (+2.8%) on Oct 27, 2026
Helus Pharma Highlights Clinical Program Advancements at Investor Presentation Held on October 21, 2026
Oct 21, 2026
Closed $14.65 (-2.7%) on Oct 22, 2026
Helus Pharma Appoints Dr. Suresh Durgam to Board of Directors
Oct 15, 2026
Closed $15.75 (+5.9%) on Oct 15, 2026
Helus Pharma to Host Investor Presentation on October 21, 2026
Oct 8, 2026
Closed $15.29 (+2.5%) on Oct 8, 2026
Helus Pharma Announces Completion of Legal Name Change
Oct 1, 2026
Closed $17.05 (-3.1%) on Oct 1, 2026
Helus Pharma Announces Results of Annual and Special Meeting of Shareholders and Effective Date for Legal Name Change
Sep 22, 2026
Closed $18.56 (-4.1%) on Sep 23, 2026
Helus Pharma to Participate at the TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit
Sep 21, 2026
Closed $19.36 (+0.6%) on Sep 22, 2026
Helus Pharma to Participate at the Morgan Stanley 24th Annual Global Healthcare Conference in New York
Sep 10, 2026
Closed $17.83 (-5.9%) on Sep 10, 2026
Helus Pharma to Participate at the H.C. Wainwright 28th Annual Global Investment Conference in New York
Sep 9, 2026
Closed $18.95 (+10.6%) on Sep 9, 2026
Financings
Public offering of common shares
Jun 25, 2026
Closed: US$50M raised · US$4.85 a share · Cantor +3
Dealers: Cantor (co-lead), Barclays (co-lead), Bloom Burton Securities Inc., Lucid Capital Markets
Use of proceeds: Advance HLP003 (depression), HLP004 (anxiety) and HLP005 programs, and working capital and general corporate purposes
At-the-market programme of common shares
Dec 30, 2025
Announced: up to US$100M · Cantor Fitzgerald and Co. +1
Dealers: Cantor Fitzgerald and Co., Cantor Fitzgerald Canada Corporation
Use of proceeds: Growth opportunities and working capital initiatives
Registered direct offering of securities in a registered direct offering
Nov 13, 2025
Closed: US$175M raised
Use of proceeds: Advance late-stage programs, prepare for commercialization and retire inefficient capital structures
Decks
Investor Presentation (August 2026)
Investor deck · 45 slides · August 2026
Helus Pharma — Technical Presentation (March 2026)
Technical · 20 slides · Mar 5, 2026
Q2 2026 Earnings Presentation
Earnings · 30 slides · Nov 13, 2025
Cybin, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 43 in the last 12 months · 56 in all · newest Nov 3, 2026 · oldest 2023
- Calls
- 3 calls with a replay · 3 with a transcript · latest Nov 13, 2025
- Decks
- 3 decks · latest August 2026
Where Cybin, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Cboe Canada:HELP · Home listing · This page | Cboe Canada | Canada | CAD |
| NASDAQ:HELP | NASDAQ | United States | USD |
| gettex:R7E | gettex | Germany | EUR |
| LS Exchange:A40NJY | LS Exchange | Germany | EUR |
| Tradegate:R7E | Tradegate | Germany | EUR |
| BOATS:HELP | BOATS | United States | USD |
| Lang & Schwarz:A40NJY | Lang & Schwarz | Germany | EUR |
| Hamburg:R7E | Hamburg | Germany | EUR |
| Stuttgart:R7E | Stuttgart | Germany | EUR |
| Munich:R7E | Munich | Germany | EUR |
| Frankfurt:R7E | Frankfurt | Germany | EUR |
| Dusseldorf:R7E | Dusseldorf | Germany | EUR |
Log in to ask 6ix AI your own questions about Cybin, Inc.